請選擇規格
¥18954
以上報價是含稅價格
規格
貨號:
規格
| 規格 | 50樣本、22樣本、8樣本、8樣本(產品加服務)、50樣本(產品加服務)、22樣本(產品加服務) |
| 樣本類型 | Cell Culture Supernatants, Plasma, Serum, Tissue Lysates, Other Body Fluids, Cell Lysates |
| 原理方法 | Sandwich-based |
| 檢測方法 | Fluorescence Laser Scanner |
| 定量與否 | Quantitative |
| 載體 | Glass Slide |
| 適用種屬 | Mouse |
| 檢測靶標 | CXCL16, MIP-2, LIX, MCP-5, MIP-1 gamma, Eotaxin-1 / CCL11, MIP-1 alpha / CCL3, RANTES / CCL5, BLC / CXCL13, MIG / CXCL9, CXCL2 / CINC-3 / MIP2, MCP-1 / CCL2, CXCL1 / GRO alpha / KC / CINC-1, MIP-3 alpha / CCL20, 6Ckine / CCL21, CTACK / CCL27, ENA-78 / CXCL5, Eotaxin-2 / MPIF-2 / CCL24, Fractalkine / CX3CL1, I-309 / TCA-3 / CCL1, I-TAC / CXCL11, MDC / CCL22, MIP-3 beta / CCL19, Platelet Factor 4 / CXCL4, SDF-1 alpha / CXCL12 alpha, TARC / CCL17, TECK / CCL25 |
| 靶標數 | 25 |
詳細描述
| Scroll over each target protein for more information | ||||
|---|---|---|---|---|
6Ckine (CCL21)
| BLC (CXCL13)
| CTACK (CCL27)
| CXCL16
| Eotaxin-1 (CCL11)
|
Eotaxin-2 (MPIF-2/CCL24)
| Fractalkine (CX3CL1)
| I-309 (TCA-3/CCL1)
| I-TAC (CXCL11)
| KC (CXCL1)
|
LIX
| MCP-1 (CCL2)
| MCP-5
| MDC (CCL22)
| MIG (CXCL9)
|
MIP-1 alpha (CCL3)
| MIP-1 gamma
| MIP-2
| MIP-3 alpha (CCL20)
| MIP-3 beta (CCL19)
|
Platelet Factor 4 (CXCL4)
| RANTES (CCL5)
| SDF-1 alpha (CXCL12 alpha)
| TARC (CCL17)
| TECK (CCL25)
|
相關產品
文件
文獻(1)
| Optimized CAR-T therapy based on spatiotemporal changes and chemotactic mechanisms of MDSCs induced by hypofractionated radiotherapy,Ni Jiali, Chen Chen, Wang Shuangan, Liu Xuan, Tan Liping, Lu Li, Fan Yu, Hou Yayi, Dou Huan, Liang Jun,ARTHRITIS RESEARCH & THERAPY ,(IF:4.9) 作者單位:南京鼓樓醫院 | |
| Species: | Mouse |
| Sample Type: | CT26 cell-Xenograft,serum |
通過郵件收到學術資源和優惠信息


微信公眾號